feed,title,long_url,short_url
ğŸ”MarketWatch,Oncternal Therapeutics started at buy with $3.50 stock price target at Maxim Group,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=ONCT&siteid=rss,https://on.mktw.net/3M40wsL
ğŸ”MarketWatch,Clean Energy Fuels upgraded to outperform from market perform at Raymond James,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CLNE&siteid=rss,https://on.mktw.net/34lXfnC
ğŸ”MarketWatch,GoodRx downgraded to market perform from outperform at Raymond James,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=GDRX&siteid=rss,https://on.mktw.net/3IBvWEU
ğŸ”MarketWatch,Heska stock price target cut to $150 from $240 at Alliance Global,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=HSKA&siteid=rss,https://on.mktw.net/3981zsN
ğŸ”MarketWatch,Construction Partners stock price target cut to $27 from $37 at Stifel Nicolaus,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=ROAD&siteid=rss,https://on.mktw.net/3N34yS5
ğŸ”MarketWatch,Crispr Therapeutics stock price target cut to $52 from $64 at Stifel Nicolaus,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CRSP&siteid=rss,https://on.mktw.net/353ywEM
ğŸ”MarketWatch,JFrog stock price target cut to $29 from $36 at Stifel Nicolaus,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=FROG&siteid=rss,https://on.mktw.net/3ehybQg
